Epigral Ltd
NSE:EPIGRAL
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
897.35
2 344.35
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one EPIGRAL stock under the Base Case scenario is 1 809.82 INR. Compared to the current market price of 2 121.1 INR, Epigral Ltd is Overvalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Epigral Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for EPIGRAL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Epigral Ltd
Balance Sheet Decomposition
Epigral Ltd
Current Assets | 5B |
Cash & Short-Term Investments | 471.4m |
Receivables | 1.8B |
Other Current Assets | 2.8B |
Non-Current Assets | 22.9B |
Long-Term Investments | 291.1m |
PP&E | 22.3B |
Intangibles | 219.6m |
Other Non-Current Assets | 138.2m |
Current Liabilities | 7.8B |
Accounts Payable | 1.7B |
Other Current Liabilities | 6.1B |
Non-Current Liabilities | 7.6B |
Long-Term Debt | 5.5B |
Other Non-Current Liabilities | 2.1B |
Earnings Waterfall
Epigral Ltd
Revenue
|
21.3B
INR
|
Cost of Revenue
|
-12.6B
INR
|
Gross Profit
|
8.6B
INR
|
Operating Expenses
|
-4.2B
INR
|
Operating Income
|
4.4B
INR
|
Other Expenses
|
-1.9B
INR
|
Net Income
|
2.5B
INR
|
Free Cash Flow Analysis
Epigral Ltd
INR | |
Free Cash Flow | INR |
EPIGRAL Profitability Score
Profitability Due Diligence
Epigral Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Epigral Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
EPIGRAL Solvency Score
Solvency Due Diligence
Epigral Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Epigral Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EPIGRAL Price Targets Summary
Epigral Ltd
According to Wall Street analysts, the average 1-year price target for EPIGRAL is 2 040 INR with a low forecast of 2 020 INR and a high forecast of 2 100 INR.
Dividends
Current shareholder yield for EPIGRAL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Meghmani Finechem Ltd. engages in the manufacture of chemicals involved in pigments and pesticides. The company is headquartered in Ahmedabad, Gujarat and currently employs 936 full-time employees. The company went IPO on 2021-08-18. The firm is engaged in manufacturing and selling chlor alkali and its derivatives. The company is also engaged in the trading of agrochemical products. The firm manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.
Contact
IPO
Employees
Officers
The intrinsic value of one EPIGRAL stock under the Base Case scenario is 1 809.82 INR.
Compared to the current market price of 2 121.1 INR, Epigral Ltd is Overvalued by 15%.